Huntington Disease Center

About Huntington Disease Center

A center with focus on clinical care and research on Huntington’s disease (HD), with the aim to develop clinical practice and novel therapies for families with HD and to bring research closer to the clinic.

News


  • Huntington centre’s MDs take part in Swedish conference

    For the first time ever, the four Swedish patients’ organizations for Alzheimer’s, Huntington, Parkinson’s and ALS are arranging a joint conference on neurodegenerative diseases. Åsa Petersén, Professor and Senior Consultant in Psychiatry, and Håkan Widner, Professor and Senior Consultant in Neurology, both active at the Huntington Disease Centre…


  • Pod on Huntington’s disease with Åsa Petersén

    Åsa Petersén has been interviewed by the website “Vetenskap & Hälsa” (Science & Health) about Huntington’s disease and the ongoing research to find a future treatment. Recent research has come up with some interesting findings, which are crucial for the development of efficient treatments Link to the pod…


  • Petersén’s talk at RHS meeting 2025

    The Swedish patients’ organisation, RHS, held their yearly meeting in October 2025 and Professor Åsa Petersén was invited speaker. Petersén’s talk addressed early symptoms in HD connected to research. The meeting was recorded and the films are now available on RHS’ website. Link to the content at RHS’…


  • Petersén gives talk at Scottish Huntington’s Association Meeting

    Petersén is invited to give a talk at the 2025 Family Gathering for the Scottish Huntington’s Association with around 170 attendees on November 8, 2025 in Glasgow. Link to the programme at the association’s webpage (opens in a new window)


  • TV4 news piece on HD gene therapy trial

    The Swedish channel TV4 published the news on the HD clinical trials that were positively described in media in late September. Professor Åsa Petersén was interviewed about the findings by TV4 and she emphasizes the need for cautiousness when interpreting the results, as they are not yet published…


  • Professor Petersén comments on the recent positive topline results from a clinical trial with gene therapy in Huntington disease presented in a press release from uniQure

    Last week, positive topline results from a clinical trial with gene therapy in Huntington disease were presented in a press release from uniQure. The news hit the headlines and spread fast through the HD community. Read Professor Petersén’s comments on these results in plain language for the wider…


  • Updated information on Huntington disease on the National Board of Health and Welfare’s webpage

    The National Board of Health and Welfare in Sweden has published updated information on Huntington disease on its’ webpage. These recent revisions of the text have been made by Professor Åsa Petersén, Lund University. Link to the National Board of Health and Welfare’s webpage – in Swedish only…

Contact

Huntington Disease Center
Klinikgatan 32
BMC D11
SE-221 84 Lund
Sweden

Chair
Åsa Petersén, Asa.Petersen@med.lu.se

Administrator
Jenny Månsson, Jenny.Mansson@med.lu.se